Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
alnylam pharmaceuticals
ambys medicines
amicus therapeutics
ampio pharmaceuticals
angelman syndrome
athenex
biomarin pharmaceutical
bluebird bio
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
centers for medicare & medicaid services
chris collins
clinical trials
column
competitive generic therapy
cystic fibrosis
deals
detroit blog main
detroit top stories
fda
gene therapy
gout
health
health insurance
healthcare
hemophilia
indiana blog main
indiana top stories
innate immunotherapeutics
ironwood pharmaceuticals
kyowa hakko kirin
lacerta therapeutics
lesinurad
life sciences
medicare
medicare advantage
millendo therapeutics
national
What
medicare
2
×
patients
2
×
separate
2
×
achieving
align
aren’t
better
bio
companies
cost
developers
dollar
drives
drug
drugs
fda
fee
gene
healthcare
help
historically
imminent
improved
incentivize
including
individual
insurance
long
lower
main
moves
news
noteworthy
opportunity
outcomes
payment
payments
prices
provide
providers
Language
Current search:
separate
×
patients
×
medicare
×
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More
@techcrunch.com
8 years ago
Fee-For-Value Drives Trillion-Dollar Healthcare Opportunity
